Item
ASCORBIC ACID USP FN GR KOSHER WEI (3020672 215 01M)
The product we supplied is allergen free.
Nutrient / Vitamin
Attributes
- Gluten-free
- Ingredient declaration
Locations
| Location name | Address |
|---|---|
| CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | No.898 Zhongshan East Road Hi-tech Industrial Development Zone Shijazhuang, China 050035 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| HACCP | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | 1. HACCP for VC.pdf | 11/10/2023 | 11/9/2026 |
| BSE - TSE | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | 12.VC TSE BSE free Statement.pdf | 3/28/2023 | 3/27/2026 |
| GRAS/NDI/ODI Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | 19. VC GRAS Statement.pdf | 8/15/2023 | 8/14/2026 |
| Allergens | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | 3.VC Allergen free Statement.pdf | 3/23/2023 | 3/22/2025 |
| CoA Sample | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | COA VC .pdf | 7/26/2022 | 7/25/2024 |
| Country of Origin | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | Country of Origin.pdf | 6/4/2024 | 6/4/2027 |
| Halal | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | Halal certificate 2026.07.26.pdf | 6/28/2022 | 6/27/2026 |
| Label Sample | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | label.jpg | 11/10/2023 | 11/9/2024 |
| Lot Code | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | Lot Code Explaination - MIFI Letterhead.doc | 11/15/2023 | 11/14/2026 |
| Nutrition | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | Nutrition Fact_Ascorbic Acid.pdf | 4/13/2023 | 4/12/2026 |
| Kosher | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | OU-kosher20240831.pdf | 8/22/2023 | 8/31/2024 |
| Product Specification Sheet | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | Specification of VC-48MONTHS.pdf | 4/12/2023 | 4/11/2026 |
| FSVP Assessment Form | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC and VC-Na FSVP Statement.pdf | 11/15/2023 | 11/14/2024 |
| HACCP Process Flow Diagram | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC flow chart CCP.pdf | 1/1/2022 | 1/1/2024 |
| Gluten | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC Gluten free Statement.pdf | 8/15/2023 | 8/14/2024 |
| Ingredient Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC Ingredient Statement.pdf | 8/15/2023 | 8/14/2024 |
| Melamine | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC Melamine free Statement.pdf | 4/27/2023 | 4/26/2024 |
| Animal Testing Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC No Animal Testing Statement.pdf | 5/7/2022 | 5/6/2024 |
| No Animal Ingredient Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC No Animal Testing Statement.pdf | 8/14/2023 | 8/13/2024 |
| GMO | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC Non-GMO Statement.pdf | 5/15/2024 | 5/15/2026 |
| Irradiation Status Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC Non-Irradiation and Non-ETO Statement.pdf | 4/28/2022 | 4/27/2024 |
| EtO Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC Non-Irradiation and Non-ETO Statement.pdf | 4/28/2022 | 4/27/2024 |
| Organic | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC Non-Organic Statement.pdf | 8/15/2023 | 8/15/2026 |
| Pesticide | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC pesticide or herbicide Free statement.pdf | 4/28/2022 | 4/27/2024 |
| Phthalate Esters Letter | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC Phthalate EstersFree Statement.pdf | 11/15/2023 | 11/14/2024 |
| California Prop. 65 | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC Pro 65 Statement.pdf | 4/20/2022 | 4/19/2024 |
| Residual Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC Residual Solvents Statement.pdf | 3/23/2023 | 3/22/2024 |
| Safety Data Sheet (SDS) | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC SDS 2022.pdf | 5/1/2022 | 4/30/2025 |
| Sewage Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC Sewage Sludge Statement.pdf | 5/19/2022 | 5/18/2024 |
| WADA/NSF/NFL Statement | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC WADA Statement.pdf | 5/19/2022 | 5/18/2024 |
| Shelf Life | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | VC-expiry date statement（48 month）.pdf | 4/1/2023 | 3/31/2026 |
| Heavy Metal | CSPC WEISHENG PHARMACEUTICAL - Shijiazhuang, China - Mitsubishi | WS_Heavy Metals Statement_Ascorbic Acid.pdf | 1/31/2023 | 1/30/2025 |
